Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-14 Purchase | 2024-05-15 4:13 pm | LENZ Therapeutics Inc. | LENZ | Chevallard Daniel R. Chief Financial Officer | 3,188 | $15.68 | $49,988 | 3,188 (Direct) | View |
| 2024-05-13 Purchase | 2024-05-14 5:29 pm | LENZ Therapeutics Inc. | LENZ | MCCOLLUM JAMES W Director | 31,332 | $15.99 | $501,093 | 620,599 (Indirect Direct) | View |
| 2024-03-21 Purchase | 2024-03-25 8:48 pm | LENZ Therapeutics Inc. | LENZ | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 998,009 | $15.03 | $15,000,075 | 792,288 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-16 Exercise | 2024-12-17 7:55 pm | N/A 2031-08-18 | LENZ Therapeutics Inc. | LENZ | Olsson Shawn Chief Commercial Officer | 3,333 | $0 | 67,974 (Direct) | View |
| 2024-12-16 Exercise | 2024-12-17 7:55 pm | N/A N/A | LENZ Therapeutics Inc. | LENZ | Olsson Shawn Chief Commercial Officer | 3,333 | $2.08 | 67,974 (Direct) | View |
| 2024-07-22 Exercise | 2024-07-23 8:16 pm | N/A 2031-03-07 | LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary | 45,000 | $0 | 387,106 (Direct) | View |
| 2024-07-22 Exercise | 2024-07-23 8:16 pm | N/A N/A | LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary | 45,000 | $1.04 | 387,106 (Direct) | View |
Ownership | 2024-03-28 4:31 pm | N/A N/A | LENZ Therapeutics Inc. | LENZ | Alpha Wave Ventures GP Ltd Alpha Wave Global LP Lunate Holding RSC Ltd Chimera Investment LLC 10% Owner | 0 | $0 | 3,612,211 (Indirect) | View |
| 2024-03-21 Option Award | 2024-03-25 8:48 pm | 2024-03-21 2027-10-30 | LENZ Therapeutics Inc. | LENZ | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,343,318 | $0 | 792,288 (Indirect) | View |
| 2024-03-21 Option Award | 2024-03-25 8:44 pm | N/A 2034-03-20 | LENZ Therapeutics Inc. | LENZ | Thunen Shelley B Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 8:42 pm | 2020-10-30 2027-10-30 | LENZ Therapeutics Inc. | LENZ | MCCOLLUM JAMES W Director | 606,209 | $0 | 622,842 (Indirect) | View |
| 2024-03-21 Option Award | 2024-03-25 8:42 pm | N/A N/A | LENZ Therapeutics Inc. | LENZ | MCCOLLUM JAMES W Director | 16,633 | $15.03 | 622,842 (Indirect) | View |
| 2024-03-21 Option Award | 2024-03-25 8:40 pm | N/A 2031-09-16 | LENZ Therapeutics Inc. | LENZ | Guerard Frederic Director | 81,468 | $0 | 81,468 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 8:40 pm | N/A 2034-03-20 | LENZ Therapeutics Inc. | LENZ | Scheiner Zachary Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 8:39 pm | N/A 2034-03-20 | LENZ Therapeutics Inc. | LENZ | Drapkin Kimberlee C Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 8:38 pm | N/A 2034-03-20 | LENZ Therapeutics Inc. | LENZ | George Jeffrey P. Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 8:36 pm | N/A 2034-03-20 | LENZ Therapeutics Inc. | LENZ | Chevallard Daniel R. Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 8:34 pm | N/A 2031-08-18 | LENZ Therapeutics Inc. | LENZ | Olsson Shawn Chief Commercial Officer | 254,355 | $0 | 254,355 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 8:33 pm | N/A 2033-06-19 | LENZ Therapeutics Inc. | LENZ | Odrich Marc Chief Medical Officer | 271,071 | $0 | 271,071 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 8:32 pm | N/A 2031-03-07 | LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary | 1,260,693 | $0 | 1,260,693 (Direct) | View |
| 2024-03-21 Other | 2024-03-25 4:30 pm | N/A N/A | LENZ Therapeutics Inc. | LENZ | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC Versant Venture Capital VII L.P. Versant Ventures VII GP L.P. Versant Ventures VII GP-GP LLC 10% Owner | 598,203 | $0 | 5,140,353 (Indirect) | View |
Ownership | 2024-03-25 4:19 pm | N/A N/A | LENZ Therapeutics Inc. | LENZ | Versant Venture Capital VII L.P. Versant Ventures VII GP L.P. Versant Ventures VII GP-GP LLC 10% Owner | 0 | $0 | 1,669,323 (Direct) | View |
| 2023-07-28 Option Award | 2023-08-01 8:09 pm | N/A 2033-07-27 | Graphite Bio Inc. | GRPH | Drapkin Kimberlee C Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:13 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | Viney Joanne L. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:12 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | Porteus Matthew Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:10 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | KARSEN PERRY A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:08 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | JIMENEZ JOSEPH Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:07 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | Jerel Davis Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:05 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | Carlo Rizzuto Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:02 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | Bassan Abraham Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:01 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | Shah Smital Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-07-19 Option Award | 2023-07-21 5:00 pm | N/A 2033-07-18 | Graphite Bio Inc. | GRPH | Hege Kristen Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 5:04 pm | N/A 2033-02-20 | Graphite Bio Inc. | GRPH | Young Alethia Chief Financial Officer | 220,000 | $0 | 220,000 (Direct) | View |